Larvol Delta - Aminex-Therapeutics-Receives-Second-FDA-Orphan-Drug-Designation-for-AMXT-1501-for-Malignant-Glioma-Including-DIPG--a-Highly-Aggressive-Childhood-Brain-Cancer

AMXT 1501 - Aminex Therap

https://www.prnewswire.com/news-releases/aminex-therapeutics-receives-second-fda-orphan-drug-designation-for-amxt-1501-for-malignant-glioma-including-dipg---a-highly-aggressive-childhood-brain-cancer-302711779.html

Mar 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next